| Ashvin K Shah, MD | |
|
2110 W 24th St, Yuma, AZ 85364-8878 | |
| (928) 344-1891 | |
| (928) 726-6306 |
| Full Name | Ashvin K Shah |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 51 Years |
| Location | 2110 W 24th St, Yuma, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013015270 | NPI | - | NPPES |
| 232421 | Medicaid | AZ |
| Facility Name | Location | Facility Type |
|---|---|---|
| Yuma Regional Medical Center | Yuma, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Aleracare Aic Llc | 8325419005 | 27 |
| Ashvin K. Shah, M.d., Pc | 0648350603 | 2 |
| Yuma Regional Medical Center | 2062314826 | 288 |
News Archive
DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.
Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.
DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.
› Verified 1 days ago
| Entity Name | Yuma Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194706655 PECOS PAC ID: 2062314826 Enrollment ID: O20040122000526 |
News Archive
DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.
Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.
DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.
› Verified 1 days ago
| Entity Name | Ashvin K. Shah, M.d., Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992915284 PECOS PAC ID: 0648350603 Enrollment ID: O20080103000038 |
News Archive
DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.
Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.
DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.
› Verified 1 days ago
| Entity Name | Vitalab Pharmacy Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073982120 PECOS PAC ID: 9032352042 Enrollment ID: O20160224001021 |
News Archive
DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.
Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.
DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.
› Verified 1 days ago
| Entity Name | Vasco Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649765801 PECOS PAC ID: 8325391865 Enrollment ID: O20181030001526 |
News Archive
DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.
Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.
DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.
› Verified 1 days ago
| Entity Name | Aleracare Aic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124735063 PECOS PAC ID: 8325419005 Enrollment ID: O20230116000785 |
News Archive
DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.
Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.
DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashvin K Shah, MD 2110 W 24th St, Yuma, AZ 85364-8878 Ph: (928) 344-1891 | Ashvin K Shah, MD 2110 W 24th St, Yuma, AZ 85364-8878 Ph: (928) 344-1891 |
News Archive
DePuy Synthes Companies is offering health care professionals a new way to track and analyze patient data in real-time and a new program to improve patients' experience with joint replacement surgery.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
The authors of a newly published paper in the September/October journal Vascular Disease Management conclude that the micro-bland embolization technique possible with Embozene(TM) Color-Advanced Microspheres leads to better clinical outcomes.
Fluxion Biosciences, Inc. announced that the new BioFlux 1000Z system for live cell imaging will be launched at the 50th American Society for Cell Biology Annual Meeting to be held December 11-15, 2010 in Philadelphia, PA. The BioFlux 1000Z is the latest addition to the BioFlux product family of instruments for cellular analysis under controlled shear flow.
DNASTAR and Scarab Genomics, sister companies founded by genomics pioneer Fred Blattner, announce the launch of a next-generation DNA and RNA sequencing services business. Using their combined expertise, the companies will be offering a full range of sequencing services including library preparation, coordinating the most appropriate sequencing technology and platform, assembly, analysis, annotation, and visualization of end results.
› Verified 1 days ago
Dr. Augustine W Lau, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 2375 S. Ridgeview Drive, Yuma, AZ 85364 Phone: 928-317-2518 Fax: 928-317-1811 | |
Aleix M. Bazzi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2095 W. 24th Street, Suite C, Yuma, AZ 85364 Phone: 928-314-1200 Fax: 928-314-1201 | |
Dr. Vernon Barros Chavez, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1210 W 24th St, Suite 2, Yuma, AZ 85364 Phone: 928-726-2500 Fax: 928-726-7853 | |
Dr. Julian J. Nicholas, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 S Avenue A, Yuma, AZ 85364 Phone: 928-344-2000 | |
Dr. Jeanne Notto Elnadry, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2244 S Avenue A, Suite A, Yuma, AZ 85364 Phone: 928-276-4477 Fax: 928-276-4481 | |
Shahid Mansoor, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 11518 N Frontage Rd Ste A, Yuma, AZ 85367 Phone: 928-342-6500 Fax: 928-342-6863 |